Research background · Updated November 1, 2026
ACE-031 Research: Publications, Study Types and Background
Short answer
ACE-031. As of November 1, 2026, PubMed indexes 12 records matching ACE-031, the earliest from 2010; 4 were published in 2021–2025 and 0 are reviews. ClinicalTrials.gov lists 4 registered studies matching the compound.
- PubMed records
- 12
- Earliest record
- 2010
- Published 2021–2025
- 4
- Reviews
- 0
- Animal-only studies
- 1
- Registered studies
- 4
Publications per year, 2006–2025
7 records in 2016–2025 against 6 in 2006–2015; the busiest year was 2010, with 2.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 0 |
| 2007 | 0 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 0 |
| 2015 | 0 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 0 |
| 2021 | 0 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 0 |
| 2025 | 2 |
Study types
| All PubMed records | 12 |
|---|---|
| Reviews | 00% |
| Animal studies (no human subjects indexed) | 18% |
| Indexed as clinical trials | 217% |
| Registered on ClinicalTrials.gov | 4 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent ACE-031 papers report, in their own authors’ terms. Each line links the paper it came from.
Lean mass and skeletal muscle
In marmosets, ACE-031, which blocks ligands of the activin receptor type IIB such as myostatin and activin A, increased lean body mass from baseline to the end of the study, which was not seen in vehicle-treated animals.
AnimalsCadena SM 2026PloS onePMID 41686840
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 12 of the 12 records. They describe what the literature is about, not what ACE-031 does.
- Activin Receptors, Type II5 papers
- Myostatin3 papers
- Muscle, Skeletal3 papers
- Neck Muscles2 papers
- Recombinant Fusion Proteins2 papers
- Performance-Enhancing Substances2 papers
- Intracranial Pressure1 papers
- Electrophoresis, Polyacrylamide Gel1 papers
Key papers
Earliest indexed record
Tomillero A (2010). Methods and findings in experimental and clinical pharmacology.
PMID 20383346Most-cited paper · 196 citations
Campbell C (2017). Muscle & nerve.
PMID 27462804Most-cited #2 · 150 citations
Attie KM (2013). Muscle & nerve.
PMID 23169607Most-cited #3 · 114 citations
Cadena SM (2010). Journal of applied physiology (Bethesda, Md. : 1985).
PMID 20466801
Citation counts from NIH iCite, among the 12 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| Identity data | On request |
|---|
Identity data from PubChem, retrieved November 1, 2026, on the ACE-031 page.
How these numbers were counted
- PubMed search, run November 1, 2026:
"ACE-031"[tiab] OR "ACE 031"[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
"ACE-031"re-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use ACE-031 outside a laboratory.
Wholesale supply
ACE-031, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
ACE-031 research questions
How much research has been published on ACE-031?
PubMed indexes 12 records matching ACE-031 (searched November 1, 2026), including 0 reviews and 2 records indexed as clinical trials. 4 were published in the five years 2021–2025.
When was ACE-031 first described in the literature?
The earliest PubMed record matching ACE-031 is from 2010 (Tomillero A, Methods and findings in experimental and clinical pharmacology, PMID 20383346).
What topics does the ACE-031 literature cover?
The subject headings PubMed indexers most often marked as a main topic of ACE-031 papers are Activin Receptors, Type II, Myostatin, Muscle, Skeletal, Neck Muscles. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is ACE-031 sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy ACE-031 wholesale for research?
We source ACE-031 to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.